Table 3.
Summary of statistically significant results of stepwise regression models
| Original cohort (PLT) | Offspring (PRPPC) | Third Generation (PLT) | Third Generation (MPV) | |||||
|---|---|---|---|---|---|---|---|---|
| Variable | Partial R2 | P-value | Partial R2 | P-value | Partial R2 | P-value | Partial R2 | P-value |
| Gender (female) | 0.041 | <.0001 | 0.003 | 0.0041 | 0.050 | <0.0001 | 0.015 | <0.0001 |
|
| ||||||||
| Age, years | 0.005 | 0.0249 | 0.008 | <0.0001 | 0.005 | 0.0001 | 0.004 | 0.0006 |
|
| ||||||||
| Hypertension medication | 0.002 | 0.0170 | ||||||
|
| ||||||||
| Cigarette smoking | 0.018 | <.0001 | 0.006 | <0.0001 | 0.004 | 0.0003 | ||
|
| ||||||||
| Aspirin use | 0.002 | 0.0378 | 0.002 | 0.0309 | ||||
|
| ||||||||
| Diabetes medication | 0.004 | 0.0005 | 0.003 | 0.0038 | ||||
|
| ||||||||
| PE/DVT (prevalence) | 0.002 | 0.0071 | ||||||
|
| ||||||||
| CVA (prevalence) | 0.004 | 0.0350 | ||||||
|
| ||||||||
| DBP (mmHg) | 0.003 | 0.0068 | 0.004 | 0.0003 | ||||
|
| ||||||||
| LDL cholesterol (mg/dL) | 0.016 | <0.0001 | ||||||
|
| ||||||||
| Total cholesterol (mg/dL) | 0.012 | 0.0005 | 0.017 | <0.0001 | ||||
|
| ||||||||
| MPV (fL) | 0.158 | <0.0001 | ||||||
|
| ||||||||
| PLT (×103/uL) | 0.158 | <0.0001 | ||||||
|
| ||||||||
| BMI | 0.011 | <0.0001 | 0.005 | 0.0001 | ||||
|
| ||||||||
| Full model R2 | 0.080 | 0.050 | 0.256 | 0.187 | ||||